Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
editorial
. 1992 Aug;89(2):170–173. doi: 10.1111/j.1365-2249.1992.tb06927.x

The spectrum of action of new immunosuppressive drugs.

A W Thomson
PMCID: PMC1554449  PMID: 1379130

Full text

PDF
170

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander A. G., Barnes N. C., Kay A. B. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet. 1992 Feb 8;339(8789):324–328. doi: 10.1016/0140-6736(92)91646-p. [DOI] [PubMed] [Google Scholar]
  2. Amemiya H., Dohi K., Otsubo O., Endo T., Nagano S., Ishibashi M., Hirano T., Sato K., Kurita T., Fukao K. Markedly enhanced therapeutic effect of deoxyspergualin on acute rejection when combined with methylprednisolone in kidney recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1087–1089. [PubMed] [Google Scholar]
  3. Baeder W. L., Sredy J., Sehgal S. N., Chang J. Y., Adams L. M. Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice. Clin Exp Immunol. 1992 Aug;89(2):174–178. doi: 10.1111/j.1365-2249.1992.tb06928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bundick R. V., Eady R. P. The effects of CP 17193, an immunosuppressive pyrazaloquinoline, on the development of spontaneous lupus disease in NZBW F1 hybrid mice. Clin Exp Immunol. 1992 Aug;89(2):179–184. doi: 10.1111/j.1365-2249.1992.tb06929.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cramer D. V., Chapman F. A., Jaffee B. D., Jones E. A., Knoop M., Hreha-Eiras G., Makowka L. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat. Transplantation. 1992 Feb;53(2):303–308. doi: 10.1097/00007890-199202010-00009. [DOI] [PubMed] [Google Scholar]
  6. Di Padova F. E. Pharmacology of cyclosporine (sandimmune). V. Pharmacological effects on immune function: in vitro studies. Pharmacol Rev. 1990 Sep;41(3):373–405. [PubMed] [Google Scholar]
  7. Dumont F. J., Staruch M. J., Koprak S. L., Melino M. R., Sigal N. H. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J Immunol. 1990 Jan 1;144(1):251–258. [PubMed] [Google Scholar]
  8. Eugui E. M., Almquist S. J., Muller C. D., Allison A. C. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol. 1991 Feb;33(2):161–173. doi: 10.1111/j.1365-3083.1991.tb03746.x. [DOI] [PubMed] [Google Scholar]
  9. Eugui E. M., Mirkovich A., Allison A. C. Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice. Scand J Immunol. 1991 Feb;33(2):175–183. doi: 10.1111/j.1365-3083.1991.tb03747.x. [DOI] [PubMed] [Google Scholar]
  10. First International Congress on FK 506. August 21-24, 1991, Pittsburgh, PA. Transplant Proc. 1991 Dec;23(6):2709–3380. [PubMed] [Google Scholar]
  11. Flanagan W. M., Corthésy B., Bram R. J., Crabtree G. R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature. 1991 Aug 29;352(6338):803–807. doi: 10.1038/352803a0. [DOI] [PubMed] [Google Scholar]
  12. Hao L., Calcinaro F., Gill R. G., Eugui E. M., Allison A. C., Lafferty K. J. Facilitation of specific tolerance induction in adult mice by RS-61443. Transplantation. 1992 Mar;53(3):590–595. doi: 10.1097/00007890-199203000-00020. [DOI] [PubMed] [Google Scholar]
  13. Kahan B. D., Chang J. Y., Sehgal S. N. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin. Transplantation. 1991 Aug;52(2):185–191. doi: 10.1097/00007890-199108000-00001. [DOI] [PubMed] [Google Scholar]
  14. Kahan B. D., Gibbons S., Tejpal N., Stepkowski S. M., Chou T. C. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation. 1991 Jan;51(1):232–239. doi: 10.1097/00007890-199101000-00038. [DOI] [PubMed] [Google Scholar]
  15. Kimball P. M., Kerman R. H., Kahan B. D. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine. Transplantation. 1991 Feb;51(2):486–490. doi: 10.1097/00007890-199102000-00041. [DOI] [PubMed] [Google Scholar]
  16. Kino T., Hatanaka H., Miyata S., Inamura N., Nishiyama M., Yajima T., Goto T., Okuhara M., Kohsaka M., Aoki H. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 1987 Sep;40(9):1256–1265. doi: 10.7164/antibiotics.40.1256. [DOI] [PubMed] [Google Scholar]
  17. Kokado Y., Ishibashi M., Jiang H., Takahara S., Sonoda T. A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation. Transplant Proc. 1989 Feb;21(1 Pt 2):1575–1578. [PubMed] [Google Scholar]
  18. Liu J., Farmer J. D., Jr, Lane W. S., Friedman J., Weissman I., Schreiber S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991 Aug 23;66(4):807–815. doi: 10.1016/0092-8674(91)90124-h. [DOI] [PubMed] [Google Scholar]
  19. Mita K., Akiyama N., Nagao T., Sugimoto H., Inoue S., Osakabe T., Nakayama Y., Yokota K., Sato K., Uchida H. Advantages of mizoribine over azathioprine in combination therapy with cyclosporine for renal transplantation. Transplant Proc. 1990 Aug;22(4):1679–1681. [PubMed] [Google Scholar]
  20. Otterness I. G. Comparative activity of CP-17,193 and five established immunosuppressives toward the antigens SRBC and EL4. Clin Exp Immunol. 1981 Nov;46(2):332–339. [PMC free article] [PubMed] [Google Scholar]
  21. Platz K. P., Sollinger H. W., Hullett D. A., Eckhoff D. E., Eugui E. M., Allison A. C. RS-61443--a new, potent immunosuppressive agent. Transplantation. 1991 Jan;51(1):27–31. doi: 10.1097/00007890-199101000-00003. [DOI] [PubMed] [Google Scholar]
  22. Ricordi C., Tzakis A. G., Carroll P. B., Zeng Y. J., Rilo H. L., Alejandro R., Shapiro A., Fung J. J., Demetris A. J., Mintz D. H. Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation. 1992 Feb;53(2):407–414. doi: 10.1097/00007890-199202010-00027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Schreiber S. L. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 1991 Jan 18;251(4991):283–287. doi: 10.1126/science.1702904. [DOI] [PubMed] [Google Scholar]
  24. Schreiber S. L., Crabtree G. R. The mechanism of action of cyclosporin A and FK506. Immunol Today. 1992 Apr;13(4):136–142. doi: 10.1016/0167-5699(92)90111-J. [DOI] [PubMed] [Google Scholar]
  25. Schreiber S. L., Liu J., Albers M. W., Karmacharya R., Koh E., Martin P. K., Rosen M. K., Standaert R. F., Wandless T. J. Immunophilin-ligand complexes as probes of intracellular signaling pathways. Transplant Proc. 1991 Dec;23(6):2839–2844. [PubMed] [Google Scholar]
  26. Sigal N. H., Dumont F., Durette P., Siekierka J. J., Peterson L., Rich D. H., Dunlap B. E., Staruch M. J., Melino M. R., Koprak S. L. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? J Exp Med. 1991 Mar 1;173(3):619–628. doi: 10.1084/jem.173.3.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sollinger H. W., Deierhoi M. H., Belzer F. O., Diethelm A. G., Kauffman R. S. RS-61443--a phase I clinical trial and pilot rescue study. Transplantation. 1992 Feb;53(2):428–432. doi: 10.1097/00007890-199202010-00031. [DOI] [PubMed] [Google Scholar]
  28. Suzuki S., Hayashi R., Kenmochi T., Shimatani K., Fukuoka T., Amemiya H. Clinical application of 15-deoxyspergualin for treatment of acute graft rejection following renal transplantation. Transplant Proc. 1990 Aug;22(4):1615–1617. [PubMed] [Google Scholar]
  29. Thomson A. W., Neild G. H. Cyclosporin: use outside transplantation. BMJ. 1991 Jan 5;302(6767):4–5. doi: 10.1136/bmj.302.6767.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tocci M. J., Matkovich D. A., Collier K. A., Kwok P., Dumont F., Lin S., Degudicibus S., Siekierka J. J., Chin J., Hutchinson N. I. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol. 1989 Jul 15;143(2):718–726. [PubMed] [Google Scholar]
  31. Todo S., Tzakis A. G., Abu-Elmagd K., Reyes J., Fung J. J., Casavilla A., Nakamura K., Yagihashi A., Jain A., Murase N. Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation. 1992 Feb;53(2):369–376. doi: 10.1097/00007890-199202010-00020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Turka L. A., Dayton J., Sinclair G., Thompson C. B., Mitchell B. S. Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine. J Clin Invest. 1991 Mar;87(3):940–948. doi: 10.1172/JCI115101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wang S. C., Zeevi A., Jordan M. L., Simmons R. L., Tweardy D. J. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. Transplant Proc. 1991 Dec;23(6):2920–2922. [PubMed] [Google Scholar]
  34. de Paulis A., Cirillo R., Ciccarelli A., Condorelli M., Marone G. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells. J Immunol. 1991 Apr 1;146(7):2374–2381. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES